The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells
Open accessAbstract
Here we show that pemetrexed-treated mesothelioma cells undergo accelerated senescence. This is characterized by the secretion of proinflammatory and mitogenic cytokines, reminiscent of an SASP (senescence-associated secretory phenotype). Conditioned media from senescent MPM (malignant pleural mesothelioma) cells trigger the emergence of EMT (epithelial-to-mesenchymal)-like, clonogenic and chemoresistant cell subpopulations, expressing high levels of ALDH (aldehyde dehydrogenase) activity (ALDH(bright) cells). We show by fluorescence-activated cell sorting of purified ALDH(bright) and ALDH(low) cells, that both cell-autonomous and cell-non-autonomous mechanisms converge to maintain the SASP-induced, EMT-like cell subpopulations. Chemoresistant ALDH(bright) cells exist within primary MPM specimens and enrichment for ALDH(bright) cells correlates with an earlier tumor onset into NOD/SCID mice. We show that RAS(v12) expression induces SASP-like changes in untransformed human mesothelial cells, and that p53 ablation increases the effect of RAS(v12) expression. We identify STAT3 activation as a crucial event downstream to SASP signaling. In fact, small hairpin RNA-mediated ablation of STAT3 deeply attenuates the induction of EMT genes and the increase of ALDH(bright) cells induced by SASP-cytokines. This strongly affects the chemoresistance of MPM cells in vitro and leads to anticancer effects in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, the SASP is able to inhibit differentiation both in vitro and in vivo, while in some cases leads to acquisition of stem cell characteristics.41,44,54,55,64–66”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [55]
In the citing paper
“Importantly, it is known that conditioned media from senescent cells can induce EMT in cell lines derived from many tumour types, including non-aggressive breast cancer, mesothelioma, and melanoma, as evidenced by decreased expression of epithelial markers (e.g. E-cadherin, cytokeratins) and increased expression of mesenchymal markers (e.g. vimentin).12,54,55”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [55]
In the citing paper
“In addition, induction of senescence and SASP in mesothelioma cells led to the emergence of a subpopulation of highly clonogenic cells with enhanced ability to form tumours when xenografted in mice.55”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Debacq-Chainiaux, F., Erusalimsky, J. D., Campisi, J., & Toussaint, O. (2009) · Nature Protocols · doi:10.1038/nprot.2009.191 · Cited by 1,668
JAK-STAT Signaling: From Interferons to Cytokines
Schindler, C., Levy, D. E., & Decker, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700016200 · Cited by 1,289
Charafe-Jauffret, E., Ginestier, C., Iovino, F., Tarpin, C., Diebel, M., Esterni, B., Houvenaeghel, G., Extra, J.-M., Bertucci, F., Jacquemier, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1630 · Cited by 732
Corney, D. C., Flesken‐Nikitin, A., Godwin, A. K., Wang, W., & Nikitin, A. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1585 · Cited by 659
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks
Liu, S., Ginestier, C., Ou, S. J., Clouthier, S. G., Patel, S. H., Monville, F., Korkaya, H., Heath, A., Dutcher, J., Kleer, C. G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0538 · Cited by 611
The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
Ma, I. W. Y., & Allan, A. L. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9208-4 · Cited by 547
Hermeking, H. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.028 · Cited by 505
Marcato, P., Dean, C. A., Pan, D., Araslanova, R., Gillis, M., Joshi, M., Helyer, L. K., Pan, L.-Z., Leidal, A. M., Gujar, S. A., et al. (2010) · Stem Cells · doi:10.1002/stem.563 · Cited by 500
When cells get stressed: an integrative view of cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420663 · Cited by 404
Cellular senescence as a tumor-suppressor mechanism
Campisi, J. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)82148-6 · Cited by 390
Epithelial to Mesenchymal Transition and Peritoneal Membrane Failure in Peritoneal Dialysis Patients
Aroeira, L. S., Aguilera, A. I., Sánchez-Tomero, J. A., Bajo, M. A., del Peso, G., Jiménez-Heffernan, J. A., Selgas, R., & López‐Cabrera, M. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006111292 · Cited by 361
STAT family of transcription factors in cytokine-mediated biological responses
Takeda, K., & Akira, S. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00005-8 · Cited by 309
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302
Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells
Kryczek, I., Liu, S., Roh, M. H., Vatan, L., Szeliga, W., Wei, S., Banerjee, M., Mao, Y., Kotarski, J., Wicha, M. S., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25967 · Cited by 275
Epithelial-Mesenchymal Transition Induced by Senescent Fibroblasts
Laberge, R.-M., Awad, P., Campisi, J., & Desprez, P.-Y. (2012) · Cancer Microenvironment · doi:10.1007/s12307-011-0069-4 · Cited by 255
Young, A. R. J., & Narita, M. (2009) · The EMBO Reports · doi:10.1038/embor.2009.22 · Cited by 214
PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth
Bais, C., Wu, X., Yao, J. J., Yang, S., Crawford, Y., McCutcheon, K. M., Tan, C., Kolumam, G. A., Vernes, J.-M., Eastham‐Anderson, J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.033 · Cited by 159
p53 and Kirsten-ras mutations in human mesothelioma cell lines.
Metcalf, R. A., Welsh, J. A., Bennett, W. P., Seddon, M. B., Lehman, T. A., Pelin, K., Linnainmaa, K., Tammilehto, L., Mattson, K. V., & Gerwin, B. I. (1992) · PubMed · Cited by 151
Cancer and aging: the importance of telomeres in genome maintenance
Rodier, F., Kim, S.-H., Nijjar, T., Yaswen, P., & Campisi, J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.012 · Cited by 132
Wang, L., Park, P., Zhang, H., Marca, F. L., & Lin, C.-Y. J. (2010) · International Journal of Cancer · doi:10.1002/ijc.25331 · Cited by 126
Kubo, T., Toyooka, S., Tsukuda, K., Sakaguchi, M., Fukazawa, T., Soh, J., Asano, H., Ueno, T., Muraoka, T., Yamamoto, H., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3040 · Cited by 125
Interleukin 8: an autocrine growth factor for malignant mesothelioma.
Gálffy, G., Mohammed, K. A., Dowling, P. A., Nasreen, N., Ward, M. J., & Antony, V. B. (1999) · PubMed · Cited by 114
Pemetrexed in Malignant Pleural Mesothelioma
Hazarika, M., White, R. M., Booth, B. P., Wang, Y.-C., Lee-Ham, D. Y., Liang, C. Y., Rahman, A., Gobburu, J. V. S., Li, N., Sridhara, R., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.982.11.3 · Cited by 108
Tolnay, E., Kuhnen, C., Wiethege, T., König, J. E., Voß, B., & Müller, K.-M. (1998) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050171 · Cited by 103
Yao, J. J., Wu, X., Zhuang, G., Kasman, I. M., Vogt, T., Phan, V. T., Shibuya, M., Ferrara, N., & Bais, C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109029108 · Cited by 102
HUANG, C., Yang, G., Jiang, T., Zhu, G., Li, H., & Qiu, Z. (2011) · Neoplasma · doi:10.4149/neo_2011_05_396 · Cited by 98
Cioce, M., Gherardi, S., Viglietto, G., Strano, S., Blandino, G., Muti, P. C., & Ciliberto, G. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12371 · Cited by 94
Self-citationAbsence of p53 Mutations in Malignant Mesotheliomas
Mor, O., Yaron, P., Huszar, M., Yellin, A., Jakobovitz-Picard, O., Brok‐Simoni, F., Rechavi, G., & Reichert, N. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.1.8998073 · Cited by 90
Prognostic significance of epithelial–mesenchymal transition in malignant pleural mesothelioma☆☆☆
Schramm, A., Opitz, I., Thies, S., Seifert, B., Moch, H., Weder, W., & Soltermann, A. (2009) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2009.08.027 · Cited by 89
Hillegass, J., Shukla, A., Lathrop, S. A., MacPherson, M. B., Beuschel, S. L., Butnor, K. J., Testa, J. R., Pass, H. I., Carbone, M., Steele, C. H., et al. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05554.x · Cited by 79
Sidi, R., Pasello, G., Opitz, I., Soltermann, A., Tutic, M., Rehrauer, H., Weder, W., Stahel, R. A., & Felley‐Bosco, E. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.09.044 · Cited by 66
Li, Q., Yano, S., Ogino, H., Wang, W., Uehara, H., Nishioka, Y., & Sone, S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0501 · Cited by 65
Suzuki, Y., Sakai, K., Ueki, J., Xu, Q., Nakamura, T., Shimada, H., Nakamura, T., & Matsumoto, K. (2010) · International Journal of Cancer · doi:10.1002/ijc.25197 · Cited by 47
Sivertsen, S., Hadar, R., Elloul, S., Vintman, L., BEDROSSIAN, C. W. M., Reich, R., & Davidson, B. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.08.010 · Cited by 42
Metastatic potential of tumor-initiating cells in solid tumors
Amit, S. A. (2010) · Frontiers in bioscience · doi:10.2741/3831 · Cited by 38
Interleukin 6 is an Autocrine Growth Factor for Normal Human Pleural Mesothelial Cells
Fujino, S., Yokoyama, A., Kohno, N., & Hiwada, K. (1996) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.14.6.8652179 · Cited by 37
Casarsa, C., Bassani, N., Ambrogi, F., Zabucchi, G., Boracchi, P., Biganzoli, E. M., & Coradini, D. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.009 · Cited by 36
STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo
Qiu, Z.-J. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1000 · Cited by 35
Mujoomdar, A. A., Tilleman, T. R., Richards, W. G., Bueno, R., & Sugarbaker, D. J. (2010) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2009.11.072 · Cited by 34
Park, J. S., Kim, Y. S., Jee, Y., Myong, N., & Lee, K. Y. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01201.x · Cited by 30
Placenta Growth Factor Expression Has Prognostic Value in Malignant Pleural Mesothelioma
Pompeo, E., Albonici, L., Doldo, E., Orlandi, A., Manzari, V., Modesti, A., & Mineo, T. C. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.04.038 · Cited by 29
Achcar, R. D., Cagle, P. T., & Jagirdar, J. S. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-1350-eoaals · Cited by 29
Oka, M., Sakaguchi, M., Okada, T., Nagai, H., Ozaki, M., Yoshioka, T., Inoue, H., Mukaida, N., Kikkawa, U., & Nishigori, C. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00972.x · Cited by 17
Epithelial to Mesenchymal Transition of Mesothelial Cells in Tuberculous Pleurisy
Kim, C., Kim, D.-G., Park, S., Hwang, Y. I., Jang, S. H., Kim, C.-H., Jung, K., Min, K., Lee, J. W., & Jang, Y. S. (2010) · Yonsei Medical Journal · doi:10.3349/ymj.2011.52.1.51 · Cited by 12
Placenta Growth Factor is a Survival Factor for Human Malignant Mesothelioma Cells
Albonici, L., Doldo, E., Palumbo, C., Orlandi, A., Bei, R., Pompeo, E., Mineo, T. C., Modesti, A., & Manzari, V. (2009) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200902200216 · Cited by 9
Scarpa, S., Giuffrida, A., Palumbo, C., Coletti, A., Cerrito, M. G., Vasaturo, F., Sinibaldi, P., Simonelli, L., Procopio, A. D., & Modesti, A. (2002) · Oncology Reports · doi:10.3892/or.9.1.205 · Cited by 9
Morgan (1996) · doi:10.1002/(sici)1096-9896(199607)179:3
Cited by
Sorted by citations
Senescence and apoptosis: dueling or complementary cell fates?
Childs, B. G., Baker, D. J., Kirkland, J. L., Campisi, J., & van Deursen, J. M. (2014) · The EMBO Reports · doi:10.15252/embr.201439245 · Cited by 915
Unmasking senescence: context-dependent effects of SASP in cancer
Faget, D. V., Ren, Q., & Stewart, S. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0156-2 · Cited by 863
How the ageing microenvironment influences tumour progression
Fane, M., & Weeraratna, A. T. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0222-9 · Cited by 849
Senescent Cells in Cancer Therapy: Friends or Foes?
Wang, B., Kohli, J., & Demaria, M. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.05.004 · Cited by 508
Aging of the cells: Insight into cellular senescence and detection Methods.
Mohamad Kamal, N. S., Safuan, S., Shamsuddin, S., & Foroozandeh, P. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151108 · Cited by 287
Metadata
- Authors
- Canino, C., Mori, F., Cambria, A., Diamantini, A., Germoni, S., Alessandrini, G., Borsellino, G., Galati, R., Battistini, L., Blandino, R., Facciolo, F., Citro, G., Strano, S., Muti, P., Blandino, G., & Cioce, M.
- Affiliations
- Instituto Nazionale Tumori Regina Elena (IT)
- Fondazione Santa Lucia (IT)
- Corresponding author
- Blandino, G
- Cioce, M
- ORCID
- Venue
- Oncogene
- Published
- 2011-10-24
- Volume
- 31
- Issue
- 26
- Pages
- 3148-3163
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2004196283
- Cited by
- 200
- References
- 50
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 18 · 2023: 15 · 2022: 18 · 2021: 25 · 2020: 17 · 2019: 16 · 2018: 14 · 2017: 4 · 2016: 18 · 2015: 15 · 2014: 8 · 2013: 7 · 2012: 4
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Funders
- Istituto Nazionale per l'Assicurazione Contro Gli Infortuni sul Lavoro
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- senescence-associated secretory phenotype, malignant pleural mesothelioma, chemoresistance, epithelial-mesenchymal transition, aldehyde dehydrogenase, cancer stem cells, pemetrexed, STAT3, RasV12, p53, cellular senescence, tumor microenvironment, cytokines, NOD/SCID xenograft
- MeSH terms
- Pemetrexed, Aldehyde Dehydrogenase, Animals, Cell Count, Cell Survival, Cell Transformation, Neoplastic, Glutamates, Guanine, Humans, Male, Mesoderm, Mesothelioma, Mitogens, Phenotype, Genes, ras, Signal Transduction, Gene Expression Regulation, Neoplastic, Cytokines, Cellular Senescence, Culture Media, Conditioned, Drug Resistance, Neoplasm, RNA, Small Interfering, Cell Line, Tumor, STAT3 Transcription Factor, Mice, Gene Knockdown Techniques, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
